Cancer, Advanced Active Not Recruiting Phase 1 Trials for Bevacizumab (DB00112)

Also known as: Advanced Cancer / Cancer / Neoplasm malignant / Malignant neoplasm NOS / Cancer NOS / Malignant tumor / Malignant tumour / Cancer (NOS) / Malignant neoplasm without specification of site

DBCOND0041606 (Cancer, Advanced)Active Not Recruiting1 IdentifierTitlePurposeDrugs
NCT00543504Bevacizumab in Multiple Phase I CombinationsTreatment
NCT01113476Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced MalignanciesTreatment
NCT01015222Dasatinib, Bevacizumab, Paclitaxel in Patients With Advanced MalignanciesTreatment
NCT01197170Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome ResistanceTreatment
NCT01187199Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced CancerTreatment